Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium thiosulfate for preservation of cardiac function after STEMI
NL-OMON47742Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing Sodium thiosulfate plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoint: Infarct size at 4 months. Started Jul 2018; status: active, not recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON47742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47742.